EP Patent

EP0161534B1 — New process for the synthesis of pyrido-imidazo-refamycins

Assigned to Alfa Wasserman SpA · Expires 1989-09-20 · 37y expired

What this patent protects

Patent listed against Xifaxan.

Drugs covered by this patent

Patent Metadata

Patent number
EP0161534B1
Jurisdiction
EP
Classification
—
Expires
1989-09-20
Drug substance claim
No
Drug product claim
No
Assignee
Alfa Wasserman SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.